Tender detail
Open-house discount agreements for flupentixol medicines (ATC N05AF01)
Summary
AOK Bayern intends to conclude non-exclusive discount agreements with interested pharmaceutical companies for medicines containing flupentixol (ATC N05AF01). Under this open-house model, the same agreement terms are offered to every company that meets the requirements. The agreements are intended to run from 1 December 2026 to 30 November 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.